Abstract
Unlike humans, rabbit corneal endothelial wounds are known to spontaneously heal. The current study was aimed to develop a new rabbit bullous keratopathy model using corneal endothelial cells that were induced to undergo endothelial-mesenchymal transformation (EMT). EMT was induced in rabbit corneal endothelial cells (RCECs) by culturing with TGFβ and basic FGF Supplemented Medium. The corneal endothelia in recipient rabbits were mechanically scraped from the corneal endothelial surface inside an 8 mm mark. Then, a suspension of EMT-induced RCECs (EMT-RCECs) was injected into the anterior chamber. Eyes injected with freshly isolated RCECs (Fresh RCECs group) and eyes that were scraped without injection of cells (Scrape group) were used as controls. Immediately following operation, subepithelial and stromal edema was observed with increased central corneal thickness and corneal opacity in all groups. In the EMT-RCECs group, bullous keratopathy persisted for 42 days up to the end of the study. In the Fresh-RCECs and Scrape groups, corneal transparency and thickness recovered by 7 days after treatment and was maintained up to 42 days. The activated fibroblast marker, α-SMA, was observed spanning from corneal endothelium to corneal stroma in the EMT-RCECs group. Interestingly, α-SMA was upregulated in the Scrape-group as well. In all groups, there was no damage to other intraocular structures, and intraocular pressure was normal throughout the observation period. Transplanting a fresh donor cornea effectively treated corneal edema due to bullous keratopathy. This model is a promising tool for pre-clinical trials in the development of new therapies against corneal endothelial dysfunction.
Similar content being viewed by others
Introduction
Corneal transparency is maintained by the corneal endothelium through the barrier function of tight junctions and by Na+/K+-ATPase pumps located along the lateral cell walls1. Corneal endothelial dysfunction causes irreversible loss of corneal transparency, and is a major cause of visual impairment and corneal blindness. Although efforts to develop pharmaceutical agents to treat corneal endothelial dysfunction demonstrate promising results2,3,4,5, corneal transplantation is still the standard treatment of choice. In order to develop new therapies for corneal endothelial disease, an animal model that resembles human corneal dysfunction is required. Several investigators have studied corneal endothelial dysfunction models using cryo-injury6,7,8, ultrasonic emulsification9, Nd:YAG laser10, chemical injury (intracameral injection of povidone–iodine11, benzalkonium bromide12 and NaOH13), mechanical scraping of corneal endothelium14 or stripping of Descemet membrane with corneal endothelium15,16,17,18. Animal species used in these models include the rabbit6,7,8,10,11,13,14,15, mouse12, rat19, cat7, pig20,21,22 and monkey9,23,24. However, the reliability and stability of small animal models are less than ideal, and monkeys are very expensive. The rabbit model is the most popular because of low cost and a similar corneal diameter compared to humans25. Unfortunately, unlike humans, rabbit corneal endothelial cells (RCECs) proliferate in vivo and wounds tend to heal spontaneously7. In addition, previous animal models have limitations such as increased intraocular pressure (IOP) or glaucoma, anterior chamber inflammation and tissue damage. Also, models that involve acute damage to the central cornea to create a defect in the corneal endothelium do not reflect the pathology of chronic bullous keratopathy in humans. A state in which chronic corneal edema occurs due to functional deterioration of diseased (or aged) corneal endothelial cells is the pathophysiology of bullous keratopathy in humans, and an appropriate animal model that mimics this state is required.
Recently, it has been shown that fibroblastic cells play a role in the healing of corneal wounds26,27. Fibroblastic cells found in the damaged corneal stroma are most likely derived from keratocytes residing in the stroma. On the other hand, corneal endothelial cells in rabbits reportedly also showed fibroblastic transformation during the wound healing process28, and IL-1β–mediated FGF-2 produced after injury reportedly alters corneal endothelial cell morphology and the actin cytoskeleton29. Basic fibroblast growth factor (bFGF) is the direct mediator for corneal endothelium modulation by cultured corneal endothelial cells30,31. It is possible that the rabbit corneal endothelial cells may transform and proliferate to a fibroblastic cell type and participate in fibroblastic role in the corneal stroma. This speculation is especially interesting when considering that corneal endothelial cells are derived from the neural crest during embryonic development, just as are the stromal keratocytes27,32. We therefore hypothesized that corneal endothelial dysfunction in humans can be imitated in a rabbit model by using corneal endothelium that were induced to undergo endothelial- mesenchymal transformation (EMT) in culture with TGFβ and basic FGF Supplemented Medium. We show how EMT-induced RCECs (EMT-RCECs) maintains corneal endothelial dysfunction for up to 42 days, which can then be treat successfully with penetrating keratoplasty.
Results
Cultivated RCECs with SEMTM undergo EMT in vitro
Fresh RCECs showed a polygonal morphology characteristic of endothelial cells. These cells were cultured and passaged with endothelial-mesenchymal transformation medium (SEMTM), and the cell morphology changed to a fibroblastic, spindle morphology. To assess the effect of RCECs cultured with TGFβ and basic FGF Supplemented Medium, the histological phenotype of RCECs was evaluated by immunofluorescence for α-SMA and vimentin as a marker of fibroblastic change. α-SMA and vimentin were evident in EMT-RCECs, whereas they were less observed in the fresh corneal endothelium (Fig. 1A). The fibroblastic marker α-Sma (p = 0.0079) was significantly upregulated after passaging RCECs (passage 5, EMT-RCECs) as shown by qRT-PCR (Fig. 1B). Western blots of vimentin, corneal endothelial markers Atp1a1 and β-actin were expressed. However, EMT-RCECs expressed significantly higher protein levels of vimentin (p = 0.048) and significantly lower levels of Atp1a1 (p = 0.0043) compared to Fresh RCECs (Fig. 1C). These findings indicated that RCECs have been induced to undergo EMT by cultured with SEMTM.
Injected EMT-RCECs show fibroblast-like cell morphology after engraftment on Descemet’s membrane
We performed immunohistochemistry for laminin in scraped and intact corneas to examine the amount of damage done to Descemet’s membrane using the scraping technique. A layer of laminin remains intact on the Descemet’s membrane surface following cell scraping. (Supplementary Fig. S1). In the rabbit corneal endothelial dysfunction model, Fresh RCECs stained with PKH26 were engrafted on Descemet’s membrane. Phalloidin staining showed polygonal morphology characteristic of RCECs (Fig. 2A). Scrape-group also showed polygonal corneal endothelial cells that were a result of normal wound healing. On the other hand, EMT-RCECs showed a fibroblast-like cell morphology (Fig. 2B). The average cell length of injected EMT-RCECs was significantly longer than the Scrape-group (p = 6.2 × 10−16) or Fresh RCECs (p = 6.4 × 10−20). Cell length was not significant different between Scrape-group and Fresh RCECs (p = 0.16). The average cell density of injected EMT-RCECs was significantly lower than the Scrape-group (p = 1.6 × 10−20) and Fresh RCECs (2.1 × 10−19). Cell density was not significant different between Scrape-group and Fresh RCECs (p = 0.37) (Fig. 2C). Six weeks after EMT-RCECs were injected in the rabbit corneal endothelial dysfunction model, flat-mount examination of the posterior side of the corneal tissue stained phalloidin showed fibroblast-like cells with irregular morphology on the Descemet’s membrane (Fig. 2D).
Long-standing rabbit bullous keratopathy model
To assess whether EMT-RCECs can be used as a tool for long-standing, non-healing corneal endothelial dysfunction, we transplanted cell suspensions in a rabbit corneal endothelium dysfunction model. Figure 3A showed corneal thickness change in the three experimental groups. During 42 days after transplantation, corneal thickness of EMT-RCECs increased over 1000 µm (at 42 days 1023.13 ± 115.73 µm) and revealed severe corneal cloudiness consistent with bullous keratopathy, whereas Scrape-group and rabbits injected with Fresh RCECs maintained significantly lower corneal thickness than EMT-RCECs by 7 days following surgery up to 42 days (Scrape-group 310.88 ± 3.20 µm, Fresh RCECs group 354.81 ± 8.63 µm). Figure 3B shows slit lamp photographs of rabbit eyes 1, 3, 7, 15 and 42 days after transplantation. Corneas of EMT-RCECs group suffered severe corneal edema and thickened stroma throughout the 42 day observation period (Fig. 3B: top panel), whereas corneas of Scrape-group and Fresh RCECs group were less edematous, and maintained transparency after 7 days (Fig. 3B: middle and bottom panel). Figure 3C shows the changes in intra ocular pressure (IOP) during the observation period. IOP was maintained within the normal range of 10–20 mmHg in all groups. There was no significant difference between groups, indicating that the difference in corneal thickness was due to EMT-RCECs pump function, but not IOP. Figure 3D shows bullae formation is observed in this model, as well as sub-epithelial changes such as neovascularization after an extended period of time. These findings indicate that EMT-RCECs after transplantation can cause bullous keratopathy in rabbits over the long term.
Immunohistochemistry and histopathological examination of EMT-RCECs-induced corneal endothelial dysfunction
Histological examination of corneal tissue 6 weeks after transplantation shows phalloidin-positive polygonal cells in the Fresh RCECs and Scrape group, while irregular fibroblastic cells were observed in the EMT-RCECs group. The main function of corneal endothelial cells is to prevent corneal edema by tight junctions formed by zonular occludens-1 (ZO-1) and Na, K-ATPase pump function. Immunohistochemistry of ZO-1 (red) and Na, K-ATPase (green) in EMT-RCECs outlined fibroblastic cell morphology, and were less expressed compared to Fresh RCECs group and Scrape-group. Immunohistochemistry revealed the localization of Na, K-ATPase and ZO-1 in cell-cell junctions, suggesting the presence of tight junctions in Scrape-group and Fresh RCECs group (Fig. 4).
Hematoxylin and Eosin (HE) at 42 days showed multilayered fibroblast-like corneal endothelial cells attached tightly on Descemet’s membrane in the EMT-RCECs group. In Fresh RCECs and Scrape-groups, a monolayer of corneal endothelial cells were observed on the Descemet’s membrane. The activated fibroblast marker α-SMA was observed spanning from the corneal endothelium to corneal stroma in the EMT-RCECs group. Interestingly, α-SMA staining was also expressed in the stroma of the Scrape-group, followed by the Fresh RCECs group. Vimentin was expressed by most stromal cells in all groups (Fig. 5).
Successful treatment of long-standing bullous keratopathy by penetrating keratoplasty (PKP)
Penetrating keratoplasty performed 7 days after injecting EMT-RCECs showed significant decrease in corneal thickness. Corneal thickness at 28 days in the PKP-treated EMT-RCECs group was lower than the untreated EMT-RCECs group (p = 1.6 × 10−4) (Fig. 6A). Anterior segment photographs of rabbit cornea 7 days after EMT-RCECs transplantation showed severe corneal edema. Eyes after penetrating keratoplasty (PKP) recovered transparency from the following day after surgery, and maintained corneal thickness and transparency (Fig. 6B). Intraocular pressure (IOP) was similar in both groups indicating that the difference in corneal thickness was not due to differences in IOP (Fig. 6C). These findings were consistent with what is observed in a clinical setting, where PKP is performed for human bullous keratopathy.
Discussion
One of the mechanism of corneal endothelial dysfunction has been explained by endothelial-mesenchymal transformation (EMT)29,33,34,35. After damage to the cornea, neutrophils infiltrate the corneal endothelium and produce IL-1β33. Interleukin-1β subsequently activates phosphatidylinositol (PI) 3-kinase, which induces synthesis of FGF-234. Fibroblast growth factor-2 triggers EMT, and forms the retrocorneal fibrous membrane characteristic of end-stage corneal endothelial disease. In this study, we developed a new rabbit corneal endothelial dysfunction model using EMT-RCECs. As far as we know, this is the first report of a suitable functional model for mimicking chronic corneal dysfunction such as Fuchs corneal endothelial dystrophy (FCED) in humans.
FCED, the most common corneal dystrophy, specifically manifests in the endothelial cell layer. The characteristic finding in FCED is the accumulation of guttae, excrescences of the Descemet’s membrane in and under the corneal endothelium. Guttae begin centrally and slowly accumulate over time, leading to endothelial cell degeneration due to increased cellular apoptosis and eventually resulting in corneal decompensation36. The underlying mechanisms for pathologic accumulation of extracelluar matrix in FCED are still not known. However, EMT has been suggested to be involved since TGFBI, a TGF-β-induced extracellular matrix protein, is increased in guttae of FCED corneas37. Multiple EMT-related gene are altered in FCED38, and as well as increased cytokines levels in the aqueous humor39. EMT-RCECs resemble chronic FECD endothelial cells in terms of decreased expression of functional corneal endothelial markers such as tight junctions formed by zonular occludens-1 (ZO-1) and Na, K-ATPase pump function. Furthermore, our model is functionally different from previous acute corneal endothelial injury models that spontaneously heal6,7,8,9,10,11,12,13,14,15,16,17,18.
Fibroblastic cells characterized by the expression of α-SMA and vimentin contribute to scarring of wounds following injury. Vimentin is expressed by most mesenchymal cells, however, the expression of α-SMA is restricted to the smooth muscle cells and a subset of fibroblastic cells designated as myofibroblasts26,40. Unlike humans, rabbit corneal endothelial wounds are known to spontaneously heal. In this study, α-SMA was observed spanning from corneal endothelium to corneal stroma in the EMT-RCECs group. This suggested myofibroblasts in corneal stroma during wound healing contribute to scarring of wound contraction. Interestingly, α-SMA was upregulated in the Scrape-group as well. It is possible that mechanical scraping of corneal endothelial cells without stripping the Descemet’s membrane may increase the myofibroblast phenotype in the deep corneal stroma. It is worth noting that transplanted Fresh-RCECs contributed to prevent such changes in the corneal stroma. It has also been reported that mechanical corneal endothelial injury in rabbits triggers apoptosis of posterior stromal cells in the short term41. Further studies are required elucidate how cell apoptosis and fibroblastic cells affects wound healing in the long term.
Levels of inflammatory cytokines in the aqueous humor are elevated during various pathologic processes such as uveitis42, post–cataract surgery43, glaucoma44, bullous keratopathy and low endothelial cell density45. We were concerned that cells cultured by TGFβ and FGF may cause various complications after transplantation into the anterior chamber. However, there was no increase in intraocular pressure and iris damage, and corneal edema outside the 8 mm zone was not observed for up to 6 weeks. Moreover, we could treat this rabbit corneal dysfunction model by PKP, which is one of the most common treatments of bullous keratopathy in humans. A clear cornea was observed following surgery, which is similar with the clinical course of PKP performed in human bullous keratopathy.
Our animal model still has limitations. First, mechanical scraping of corneal endothelium without damaging Descemet’s membrane may require a learning curve. Second, general anesthesia is required during the experiment, which may cause unintentional death of experimental animals. Third, rabbit corneal endothelial cells have different regeneration capacity compared with humans. However, despite the regeneration ability, our model showed sustained corneal endothelial dysfunction for 6 weeks. It is possible that a similar model can be used in other animal species such as mice and primates. However, rabbits are probably ideal due to the low cost and similar anatomical features with humans such as corneal diameter and thickness46, corneal endothelial density, and decrease in corneal diameter with age47,48. The mechanism of how transplanted EMT-RCECs in our model causes bullous keratopathy still needs clarification. Corneal edema may also be the result of epithelial dysfunction in addition to endothelial damage49. Our model is created by mechanical injury, and corneal edema is followed by epithelial bullae and subepithelial neovascularization. However, the rabbit does not have the Bowman’s layer, therefore, while our model is similar to human disease, it may not completely the same in the long term.
In summary, injection of EMT-induced RCECs within an 8-mm diameter zone of the endothelium can effectively induce bullous keratopathy in rabbits. Transplanted EMT-RCECs maintained bullous keratopathy for up to 42 days, which is much longer than acute injury models. Furthermore, the long-standing edema could be effectively treated by penetrating keratoplasty suggesting that this model is a promising tool for testing new therapies against corneal endothelial dysfunction.
Methods
Animal experiment approval
In all experiments, animals were housed and treated in accordance with The Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research. The rabbit experiments were performed at Tokyo Dental College Ichikawa General Hospital (Ichikawa, Japan) according to the protocol approved by that university’s Animal Care and Use Committee (approval No. 297607).
Fresh rabbit corneal endothelial cells
Eyes of Japanese white rabbits (Cat. No.J404 Funakoshi Corporation, Tokyo, Japan http://www.funakoshi.co.jp) were purchased. After enucleating the lens from the rabbit eye, the corneal endothelium, along with the Descemet’s membrane, was mechanically isolated from the cornea, removing as much tissue as possible. The isolated corneal endothelial tissue was incubated with Accutase (Cat. No. 1967954, Nacalai tesque) at 37 °C, in a humidified atmosphere of 5% CO2 on 35 mm dish for 30 min. After gently pipetting, the suspension was poured into a conical tube (TPP, Techno Plastic Products AG, Trasadingen, Switzerland, www.tpp.ch) through a 70 µm filter (Cat. No.352350, Falcon, Corning, NY, http://www.corning.com) to obtain single cell suspensions. Dissociated cells were centrifuged at 400 g 10 min and handled with DMEM/F12 (Cat. No. 08460-95, Nacalai tesque, Kyoto, Japan, https://www.nacalai.co.jp) supplemented with 10% fetal bovine serum (Sigma-Aldrich, St. Louis, MO, http://www.sigmaaldrich.com), penicillin (50 U/mL; Sigma-Aldrich) and streptomycin (50 μg/mL; Sigma-Aldrich). The freshly isolated RCECs were labeled with the fluorescent tracker, PKH26 (Cat. No. PKH26GL, Sigma-Aldrich) to observe cell localization after transplantation.
EMT Cell culture
The isolated rabbit corneal endothelial cells, as noted above, were incubated at 37 °C, in a humidified atmosphere of 5% CO2 on 35 mm dish in the specific endothelial-mesenchymal transformation medium (SEMTM). The SEMTM was based on DMEM/F12 (Nacalai tesque) supplemented with 10% fetal bovine serum (Sigma-Aldrich), 1 ng/mL transforming growth factor (TGF) β1 (Cat. No. 240-GMP-010, R&D systems, Inc. Minneapolis, MN. USA. https://www.rndsystems.com) penicillin (100 U/mL; Sigma-Aldrich), streptomycin (100 μg/mL; Sigma-Aldrich), 1% Insulin, Transferrin, Selenium Solution (ITS-G) (Cat.No.I3146, Sigma-Aldrich), 20 ng/mL of basic fibroblast growth factor (Cat. No.AF-100-18B, PeproTech. Rocky Hill, NJ, United States. https://www.peprotech.com), 2 mM L-Ala, L-Glutamain (Cat. No.04260-64, Nacalai tesque). The SEMTM was changed every 2 days until the cells reached confluence. The harvested cells were incubated in 2 ml Accutase (Nacalai tesque) on 35 mm dish for 20 min at 37 °C after washing 3 times with phosphate-buffered saline (PBS) for passage. The suspension in 35 mm dish was poured into a conical tube (Techno Plastic Products) through a 70 µm filter (Falcon, Corning) to obtain single cell suspensions. Dissociated cells were centrifuged at 400 g 10 min and suspended 5.0 × 105 cells in 25 cm2 flask with SEMTM. The harvested cells were passaged until passage 5, at which point cells were used for experimental analyses.
Immunocytochemistry
Immunocytochemical analyses of cultured cells and fresh cornea samples were performed as described previously50. In brief, the cells were fixed at room temperature for 10 min in 4% formaldehyde in PBS. After 3-time PBS washes, the specimens were incubated for 30 min in Morphosave (Cat.No.250-010, Ventana Medical Systems, Inc., Tucson, Arizona, http://www.ventana.com). After 2-time PBS washes, the specimens were incubated for 30 min in 10% normal donkey serum to block nonspecific binding. This was followed by overnight incubation at 4 °C with 1: 200-diluted mouse anti-Tight junction protein 1 (ZO-1) monoclonal antibody (Cat. No. 33-910-0, Thermo Fisher Scientific, Waltham, MA, https://www.thermofisher.com) or 1: 200-diluted mouse Na, K-ATPase α1 subunit antibody (Cat.No.NB300-146, Novus Biologicals, Littleton, CO, http://www.novusbio.com) or 1: 200-diluted mouse anti-actin, α-smooth muscle-Cy3™ antibody (Cat.No.C6198, Sigma-Aldrich) or 1: 200-diluted Alexa Flour 488-Phalloidin (Cat. No.A12379, Invitrogen, Thermo Fisher Scientific, Massachusetts, USA. www.thermofisher.com) and 3-time washes in PBS. The samples were then incubated for 2 hours in a 1: 200 dilution of Cy3-conjugated donkey anti-mouse IgG antibody (Cat.No.715-165-151, Jackson ImmunoResearch Laboratories, West Grove, PA, http://www.jacksonimmuno.com) or Alexa Flour 488 conjugated donkey anti-mouse IgG antibody (Cat.No.A21202, life technologies) and again washed 3 times in the dark. Finally, the samples were mounted on dishes with an anti-fading mounting medium containing 4′,6-diamidino-2-phenylindole ([DAPI] 1 mg/ml, Cat.No.D523 Dojindo Laboratories, Kumamoto, Japan, http://www.dojindo.com). Images were obtained by fluorescent microscopy Axio imager (Carl Zeiss, Inc., Weimar, Germany, http://www.zeiss.com).
RT-PCR analysis and quantitative RT-PCR analysis
Real-time RT-PCR and quantitative RT-PCR were performed as described previously50. Total RNA was purified with the use of RNeasy kit (Qiagen, Hilden, Germany, http://www.qiagen.com) and cDNA was synthesized from total RNA using the Rever Tra Ace cDNA Synthesis Kit (TOYOBO Co., Ltd., Osaka, Japan, http://www.toyobo-global.com), according to the manufacturer’s protocol. Polymerase chain reaction (PCR) was performed using Verti Thermal Cycler (Applied Biosystems, Thermo Fisher Scientific Inc.). Quantitative real time PCR with the Thunderbird SYBR qPCR Mix (TOYOBO) was performed using the Step One real-time PCR system (Applied Biosystems) in duplicate or triplicate. The primer sequences used are as follows51: α-Sma, 5′-TCTGTAAGGCCGGCTTTGC-3′ and 5′-TGTCCCATTCCCACCATCA-3′; GAPDH, 5′-ACAGTCGCCGCATCTTCTT-3′ and 5′-CTTGATTTTGGAGGGATCTCGC-3′.
Western blot analysis
Western blot analyses were performed as described previously50,52. Fresh RCECs and EMT-RCECs were washed with PBS twice, and dissolved in a lysis buffer (M-PER; Thermo Fisher Scientific Inc.) with a protein inhibitor cocktail (Thermo Fisher Scientific Inc.). Western blot analysis was performed by using a standard protocol with primary antibodies for β-actin (Cat. No. ab16039, Abcam, Cambridge, U.K., http://www.abcam.com), Atp1a1 (Na-K-ATPase α-subunit) (Cat. No. NB300-146, Novus Biologicals, Littleton, Colorado, USA. http://www.novusbio.com), and Vimentin (Cat. No. sc-7557, Santa Cruz Biotechnology, Dallas, Texas, http://www.scbt.com). Chemiluminescence images were analyzed using a Charge-Coupled Device camera system (ImageQuant LAS 4000; GE Healthcare, Little Chalfont, U.K., http://www.gehealthcare.com).
Rabbit corneal endothelial dysfunction model by injection of RCECs
Rabbit corneal endothelial dysfunction was created by modifying a previous report14. Japanese white rabbits (female, 2.5 kg body weight; Shiraishi Experimental Animal Breeding Farm) were anesthetized intravenously with a mixture of medetomidine hydrochloricde (0.5 mg/kg; Domitor; Meiji Seika Pharma Co., Ltd, Tokyo, Japan. http://www.meiji-seika-pharma.co.jp), midazolam hydrochlride (2.0 mg/kg; Dormicaum; Astellas Pharma, Tokyo, Japan https://www.astellas.com), and butorphanol (0.5 mg/kg; Vetorphale; Meiji Seika Pharma Co., Ltd.). Transplantation was performed on the left eye only of each animal and was performed in an animal surgery room. As preoperative treatment, Mydrin-P™ (Tropicamide Phenylephrine hydrochloride, Santen Pharmaceutical Co., Ltd, Osaka, Japan, https://www.santen.co.jp) eye drop was instilled 10 minutes before surgery. Marking was done by placing a blue pigment with Devon™ Surgical Skin Markers (Cat. No.31145942, Covidien, Medtronic plc, Dublin, Ireland. http://www.medtronic.com) on the blade of an 8 mm disposable biopsy punch (Cat. No.BP-80F, Kai medical, Tokyo, Japan. http://www.kai-group.com) and placing it vertically on the corneal epithelium. Next, the anterior chamber was punctured with a 22.5 ° straight knife (Cat. No.MST22, MANI, Tochigi, Japan. http://www.mani.co.jp) from the corneal limbus. To maintain space in the anterior chamber, OPEGAN Hi™ (Purified Sodium Hyaluronate, Santen Pharmaceutical Co., Ltd.) was injected through the puncture with a 27 G blunt needle. The corneal endothelium was mechanically scraped with a 20-gauge silicone needle (soft tapered needle; Inami, Tokyo, Japan. http://inami.co.jp) from the corneal endothelial surface within the 8 mm mark. The scraped area was confirmed by 0.04% trypan blue staining during surgery. This scraping technique and trypan blue staining were performed as described previously14,23. Then, the anterior chamber was irrigated with physiological saline using the Aspiration/Irrigation Unit SIMCOE™ Original Model tube (Cat. No.M-104, Inami, Tokyo, Japan). After a single suturing of 10-0 nylon, 160 µl of cell suspension was injected into the anterior chamber with a 27 gauge needle. Injected cells include cultivated RCECs and Fresh RCECs. A total of 3.0 × 105 cells were suspended in 160 μl SHELLGAN™ (Purified Sodium Hyaluronate and Chondroitin Sulfate Sodium, Santen Pharmaceutical Co., Ltd, Osaka, Japan.) during injection. Endothelial scraping alone with no cell injection served as control (Scrape-group). The cornea was gently tapped to homogenize cell distribution in the anterior chamber. The operated eye was kept in a face-down position for 3 hours under general anesthesia.
Antibiotic (0.3% ofloxacin) and steroid (0.1% betamethasone) eye drops were applied topically 2 times a day. Following surgery, rabbits were carefully observed by slit-lamp microscopy, and serial photographs were obtained. Central corneal thickness was measured with an ultrasound pachymeter (Tomey, Aichi, Japan. https://www.tomey.co.jp), and intraocular pressure (IOP) was measured by Accupen (White Medical, Tokyo, Japan. http://www.whitemedical.co.jp) every 1–2 days for the first week, and then once every 2–3 days for the following 2 weeks and once every week for the following 6 weeks. Central corneal thickness measurement and IOP measurement were performed by 2 different investigators who were masked to the details of transplantation in each group. 12 eyes from 12 individual rabbits were used for each experimental group. Finally, 6 weeks after surgery, rabbits were sacrificed using the above-described anesthesia, 20 mg/kg Thiopental sodium (Ravonal, Mitsubishi Tanabe Pharma Co., Osaka, Japan. http://www.mt-pharma.co.jp), and 90 ml/kg 1 N potassium chloride (Wako, Pure Chemical Industries, Tokyo, Japan).
Measurement of cell diameter and density
The size of corneal endothelial wounds and expansion of injected cells were measured and counted manually in randomly selected fields (n = 25), and cell density measured was measured within a square with 50 μm on one side. Images were captured at 200 x magnification for each section using a fluorescent microscopy Axio imager (Carl Zeiss, Inc.) and repeated three times under independent conditions.
Histological examination of rabbit eyes after RCECs injection
After rabbits were sacrificed, the operated eyes were enucleated, and the cornea of each operated eye was cut, paraffin-embedded, and mounted on dishes or glass slides with an anti-fading mounting medium. The enucleated eyes were excised and fixed in 4% paraformaldehyde for 18 h. The corneal paraffin sections were used for Hematoxylin and Eosin (HE) staining, α-smooth muscle clone 1A4 antibody (Cat. No. A2547, Sigma-Aldrich, St. Louis, MO, http://www.sigmaaldrich.com) staining, vimentin (Cat. No. M0725; DAKO) staining and laminin (Cat. No. Z0097; DAKO) staining. Immunohistochemistry (IHC) staining was done automatically by BOND-MAX™ (IHC staining system, Leica Microsystems GmbH, Leica, Wetzlar, Germany, https://leica-camera.com/). The corneal images were obtained by use of a microscope BZ-9000™ (Keyence, Osaka City, Osaka, Japan, https://www.keyence.co.jp).
Penetrating keratoplasty (PKP)
Penetrating keratoplasty (PKP) study performed by modifying a previous report50.
Japanese white rabbits (female, 2.5 kg body weight; Shiraishi Experimental Animal Breeding Farm) were anesthetized intravenously with a mixture of medetomidine hydrochloricde (0.5 mg/kg; Domitor; Meiji Seika Pharma Co., Ltd.), midazolam hydrochlride (2.0 mg/kg; Dormicaum; Astellas Pharma.), and butorphanol (0.5 mg/kg; Vetorphale; Meiji Seika Pharma Co., Ltd.). Transplantation was performed in an animal surgery room on the left eye only of each animal. As preoperative treatment, Mydrin-P™ (Tropicamide Phenylephrine hydrochloride, Santen Pharmaceutical Co., Ltd.) eye drop was instilled 10 minutes before surgery. Corneal buttons were prepared from donor corneas purchased from Funakoshi Co., Ltd using an 8.0-mm Barron donor cornea punch (Barron Precision Instruments, Grand Blanc, MI, USA. http://www.bpic.com). The recipient cornea was cut using a 7.5-mm Hassburg-Barron Vacuum Trephine (Cat. No. 21-8275, Barron Precision Instruments), and the corneal buttons were then sutured on the graft bed with 16 interrupted sutures (10–0 nylon). Three rabbits were transplanted with fresh corneas 7 days after EMT-RCECs injection. Antibiotics (0.3% ofloxacin) and steroids (0.1% betamethasone) were applied topically 2 times a day. After transplantation, eyes were carefully observed by slit-lamp microscopy, and serial photographs were obtained. Central corneal thickness was measured with an ultrasound pachymeter (Tomey), and intraocular pressure (IOP) was measured by Accupen (Accutome, Inc.) every 1–2 days for the first week, and then once every 2–3 days for the following 2 weeks, and once every week for the following 4 weeks. Another 3 rabbits from the EMT-RCECs group were followed without surgery as control. Finally, 28 days after surgery, rabbits were sacrificed (above-described anesthesia, 20 mg/kg Thiopental sodium (Ravonal, Tanabe Seiyaku Co., Osaka, Japan.), and 90 ml/kg 1 N potassium chloride (Wako, Pure Chemical Industries).
Statistical analysis
Data are presented as mean ± SD and were compared by Student’s t-test or multiple t-test with Bonferroni correction after ANOVA using the Excel 2007 software (Microsoft corporation, Redmond, WA, USA, http://www.microsoft.com). P value of <0.05 was considered statistically significant.
References
Bourne, W. M. Clinical estimation of corneal endothelial pump function. Transactions of the American Ophthalmological Society 96, 229–239, discussion 239-242 (1998).
Lu, J. et al. TGF-beta2 inhibits AKT activation and FGF-2-induced corneal endothelial cell proliferation. Exp Cell Res 312, 3631–3640, https://doi.org/10.1016/j.yexcr.2006.08.004 (2006).
Nakano, Y. et al. Connexin43 knockdown accelerates wound healing but inhibits mesenchymal transition after corneal endothelial injury in vivo. Invest Ophthalmol Vis Sci 49, 93–104, https://doi.org/10.1167/iovs.07-0255 (2008).
Hoppenreijs, V. P., Pels, E., Vrensen, G. F. & Treffers, W. F. Corneal endothelium and growth factors. Survey of ophthalmology 41, 155–164 (1996).
Okumura, N. et al. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing. Invest Ophthalmol Vis Sci 54, 2493–2502, https://doi.org/10.1167/iovs.12-11320 (2013).
Minkowski, J. S. et al. Corneal endothelial function and structure following cryo-injury in the rabbit. Invest Ophthalmol Vis Sci 25, 1416–1425 (1984).
Van Horn, D. L., Sendele, D. D., Seideman, S. & Buco, P. J. Regenerative capacity of the corneal endothelium in rabbit and cat. Invest Ophthalmol Vis Sci 16, 597–613 (1977).
Staatz, W. D. & Van Horn, D. L. The effects of aging and inflammation on corneal endothelial wound healing in rabbits. Invest Ophthalmol Vis Sci 19, 983–986 (1980).
Wu, M., Hu, Z. L., Sun, X. M. & Dai, J. J. In Vivo Confocal Microscopic Evaluation of Corneal Endothelial Dysfunction Induced by Phacoemulcification in Rhesus Monkey Models. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 38, 42–48, https://doi.org/10.3881/j.issn.1000-503X.2016.01.008 (2016).
Zhang, W. et al. Rabbit Model of Corneal Endothelial Injury Established Using the Nd: YAG Laser. Cornea 36, 1274–1281, https://doi.org/10.1097/ico.0000000000001324 (2017).
ElKitkat, R. S., Ebeid, W. M., Habib, E. K. & Shoukry, Y. Safety of Intracameral Injection of Minimal Bactericidal Concentration of Povidone Iodine on the Corneal Endothelium in a Rabbit Model. Cornea 35, 72–76, https://doi.org/10.1097/ico.0000000000000682 (2016).
Hayashi, T. et al. A mouse model of allogeneic corneal endothelial cell transplantation. Cornea 27, 699–705, https://doi.org/10.1097/QAI.0b013e31815e722b (2008).
Choi, S. O. et al. Recovery of Corneal Endothelial Cells from Periphery after Injury. PLoS One 10, e0138076, https://doi.org/10.1371/journal.pone.0138076 (2015).
Okumura, N. et al. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue. The American journal of pathology 181, 268–277, https://doi.org/10.1016/j.ajpath.2012.03.033 (2012).
Shao, C. et al. Targeted transplantation of human umbilical cord blood endothelial progenitor cells with immunomagnetic nanoparticles to repair corneal endothelium defect. Stem Cells Dev 24, 756–767, https://doi.org/10.1089/scd.2014.0255 (2015).
Maurice, D. M. & Giardini, A. A. Swelling of the cornea in vivo after the destruction of its limiting layers. Br J Ophthalmol 35, 791–797 (1951).
Stocker, F. W. The endothelium of the cornea and its clinical implications. Transactions of the American Ophthalmological Society 51, 669–786 (1953).
Peh, G. S. L. et al. Regulatory Compliant Tissue-Engineered Human Corneal Endothelial Grafts Restore Corneal Function of Rabbits with Bullous Keratopathy. Scientific reports 7, 14149, https://doi.org/10.1038/s41598-017-14723-z (2017).
Tuft, S. J., Williams, K. A. & Coster, D. J. Endothelial repair in the rat cornea. Invest Ophthalmol Vis Sci 27, 1199–1204 (1986).
Asano-Kato, N., Toda, I., Hori-Komai, Y., Takano, Y. & Tsubota, K. Epithelial ingrowth after laser in situ keratomileusis: clinical features and possible mechanisms. American journal of ophthalmology 134, 801–807 (2002).
Hwang, H. & Kim, M. Endothelial damage of a donor cornea depending on the donor insertion method during Descemet-stripping automated endothelial keratoplasty in porcine eyes. Jpn J Ophthalmol 53, 523–530, https://doi.org/10.1007/s10384-009-0713-4 (2009).
Sweatt, A. J., Ford, J. G. & Davis, R. M. Wound healing following anterior keratectomy and lamellar keratoplasty in the pig. Journal of refractive surgery (Thorofare, N.J. : 1995) 15, 636–647 (1999).
Koizumi, N. et al. Cultivated corneal endothelial cell sheet transplantation in a primate model. Invest Ophthalmol Vis Sci 48, 4519–4526, https://doi.org/10.1167/iovs.07-0567 (2007).
Koizumi, N. et al. Cultivated corneal endothelial transplantation in a primate: possible future clinical application in corneal endothelial regenerative medicine. Cornea 27(Suppl 1), S48–55, https://doi.org/10.1097/ICO.0b013e31817f2298 (2008).
Prinsen, M. K., Hendriksen, C. F., Krul, C. A. & Woutersen, R. A. The Isolated Chicken Eye test to replace the Draize test in rabbits. Regulatory toxicology and pharmacology: RTP 85, 132–149, https://doi.org/10.1016/j.yrtph.2017.01.009 (2017).
Garana, R. M. et al. Radial keratotomy. II. Role of the myofibroblast in corneal wound contraction. Invest Ophthalmol Vis Sci 33, 3271–3282 (1992).
Ishizaki, M., Zhu, G., Haseba, T., Shafer, S. S. & Kao, W. W. Expression of collagen I, smooth muscle alpha-actin, and vimentin during the healing of alkali-burned and lacerated corneas. Invest Ophthalmol Vis Sci 34, 3320–3328 (1993).
Ichijima, H. et al. In vivo confocal microscopic studies of endothelial wound healing in rabbit cornea. Cornea 12, 369–378 (1993).
Lee, H. T., Lee, J. G., Na, M. & Kay, E. P. FGF-2 induced by interleukin-1 beta through the action of phosphatidylinositol 3-kinase mediates endothelial mesenchymal transformation in corneal endothelial cells. The Journal of biological chemistry 279, 32325–32332, https://doi.org/10.1074/jbc.M405208200 (2004).
Kay, E. P., Gu, X., Ninomiya, Y. & Smith, R. E. Corneal endothelial modulation: a factor released by leukocytes induces basic fibroblast growth factor that modulates cell shape and collagen. Invest Ophthalmol Vis Sci 34, 663–672 (1993).
Kay, E. P., Gu, X. & Smith, R. E. Corneal endothelial modulation: bFGF as direct mediator and corneal endothelium modulation factor as inducer. Invest Ophthalmol Vis Sci 35, 2427–2435 (1994).
Hay, E. D. Development of the vertebrate cornea. International review of cytology 63, 263–322 (1980).
Lee, J. G., Ko, M. K. & Kay, E. P. Endothelial mesenchymal transformation mediated by IL-1beta-induced FGF-2 in corneal endothelial cells. Experimental eye research 95, 35–39, https://doi.org/10.1016/j.exer.2011.08.003 (2012).
Song, J. S., Lee, J. G. & Kay, E. P. Induction of FGF-2 synthesis by IL-1beta in aqueous humor through P13-kinase and p38 in rabbit corneal endothelium. Invest Ophthalmol Vis Sci 51, 822–829, https://doi.org/10.1167/iovs.09-4240 (2010).
Lee, J. G. & Kay, E. P. Common and distinct pathways for cellular activities in FGF-2 signaling induced by IL-1beta in corneal endothelial cells. Invest Ophthalmol Vis Sci 50, 2067–2076, https://doi.org/10.1167/iovs.08-3135 (2009).
Eghrari, A. O., Riazuddin, S. A. & Gottsch, J. D. Fuchs Corneal Dystrophy. Progress in molecular biology and translational science 134, 79–97, https://doi.org/10.1016/bs.pmbts.2015.04.005 (2015).
Jurkunas, U. V., Bitar, M. & Rawe, I. Colocalization of increased transforming growth factor-beta-induced protein (TGFBIp) and Clusterin in Fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci 50, 1129–1136, https://doi.org/10.1167/iovs.08-2525 (2009).
Iliff, B. W., Riazuddin, S. A. & Gottsch, J. D. The genetics of Fuchs’ corneal dystrophy. Expert review of ophthalmology 7, 363–375, https://doi.org/10.1586/eop.12.39 (2012).
Matthaei, M. et al. Epithelial-Mesenchymal Transition (EMT)-Related Cytokines in the Aqueous Humor of Phakic and Pseudophakic Fuchs’ Dystrophy Eyes. Invest Ophthalmol Vis Sci 56, 2749–2754, https://doi.org/10.1167/iovs.15-16395 (2015).
Majno, G., Gabbiani, G., Hirschel, B. J., Ryan, G. B. & Statkov, P. R. Contraction of granulation tissue in vitro: similarity to smooth muscle. Science 173, 548–550 (1971).
Medeiros, C. S., Lassance, L., Saikia, P., Santhiago, M. & Wilson, S. E. Posterior stromal cell apoptosis triggered by mechanical endothelial injury and basement membrane component nidogen-1 production in the cornea. Experimental eye research 172, 30–35, https://doi.org/10.1016/j.exer.2018.03.025 (2018).
El-Asrar, A. M. et al. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clinical immunology (Orlando, Fla.) 139, 177–184, https://doi.org/10.1016/j.clim.2011.01.014 (2011).
Kawai, M. et al. Elevated levels of monocyte chemoattractant protein-1 in the aqueous humor after phacoemulsification. Invest Ophthalmol Vis Sci 53, 7951–7960, https://doi.org/10.1167/iovs.12-10231 (2012).
Takai, Y., Tanito, M. & Ohira, A. Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract. Invest Ophthalmol Vis Sci 53, 241–247, https://doi.org/10.1167/iovs.11-8434 (2012).
Yamaguchi, T. et al. Elevated Cytokine Levels in the Aqueous Humor of Eyes With Bullous Keratopathy and Low Endothelial Cell Density. Invest Ophthalmol Vis Sci 57, 5954–5962, https://doi.org/10.1167/iovs.16-20187 (2016).
Valdez-Garcia, J. E., Lozano-Ramirez, J. F. & Zavala, J. Adult white New Zealand rabbit as suitable model for corneal endothelial engineering. BMC research notes 8, 28, https://doi.org/10.1186/s13104-015-0995-1 (2015).
Morita, H. Specular microscopy of corneal endothelial cells in rabbits. The Journal of veterinary medical science 57, 273–277 (1995).
Doughty, M. J. The cornea and corneal endothelium in the aged rabbit. Optometry and vision science: official publication of the American Academy of Optometry 71, 809–818 (1994).
Ljubimov, A. V. et al. Extracellular matrix and Na+, K+ -ATPase in human corneas following cataract surgery: comparison with bullous keratopathy and Fuchs’ dystrophy corneas. Cornea 21, 74–80 (2002).
Hatou, S. et al. Functional corneal endothelium derived from corneal stroma stem cells of neural crest origin by retinoic acid and Wnt/beta-catenin signaling. Stem Cells Dev 22, 828–839, https://doi.org/10.1089/scd.2012.0286 (2013).
Ishikawa, K. et al. Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy. Scientific reports 5, 16386, https://doi.org/10.1038/srep16386 (2015).
Inagaki, E. et al. Skin-Derived Precursors as a Source of Progenitors for Corneal Endothelial Regeneration. Stem Cells Transl Med 6, 788–798, https://doi.org/10.1002/sctm.16-0162 (2017).
Acknowledgements
We thank Terumasa Suzuki for technical assistance and Dr. Hideyuki Miyashita for general support. We thank the Department of Pathology, Keio University School of Medicine, for technical support and reagents.
Author information
Authors and Affiliations
Contributions
K.Y. Conception and design, Collection and assembly of data, Data analysis and interpretation, Manuscript writing. S.H. Conception and design, Collection and assembly of data, Data analysis and interpretation. K.H. Collection and assembly of data E.I. and K.T. Conception and design. S.S. Conception and design, manuscript writing, final approval of manuscript.
Corresponding author
Ethics declarations
Competing Interests
This work was supported by the Research Project for Practical Applications of Regenerative Medicine from Japan Agency for Medical Research and development, AMED under Grant Number JP18bk0104049. Funders were not involved with any part of the study design or interpretation of the data.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yamashita, K., Hatou, S., Inagaki, E. et al. A Rabbit Corneal Endothelial Dysfunction Model Using Endothelial-Mesenchymal Transformed Cells. Sci Rep 8, 16868 (2018). https://doi.org/10.1038/s41598-018-35110-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-018-35110-2
Keywords
This article is cited by
-
Transplantation of human induced pluripotent stem cell-derived neural crest cells for corneal endothelial regeneration
Stem Cell Research & Therapy (2021)
-
“Reversed polarization” of Na/K-ATPase—a sign of inverted transport in the human endolymphatic sac: a super-resolution structured illumination microscopy (SR-SIM) study
Cell and Tissue Research (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.